Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) was upgraded by JMP Securities from a “market perform” rating to an “outperform” rating in a note issued to investors on Friday. The firm presently has a $115.00 price target on the pharmaceutical company’s stock, up from their previous price target of $103.73. JMP Securities’ price objective suggests a potential upside […]
